A detailed history of Natixis Advisors, L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,121,306 shares of ZTS stock, worth $186 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
1,121,306
Previous 1,088,899 2.98%
Holding current value
$186 Million
Previous $189 Million 16.06%
% of portfolio
0.43%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$172.58 - $196.48 $5.59 Million - $6.37 Million
32,407 Added 2.98%
1,121,306 $219 Million
Q2 2024

Aug 01, 2024

BUY
$145.54 - $178.83 $7.83 Million - $9.63 Million
53,831 Added 5.2%
1,088,899 $189 Million
Q1 2024

Apr 25, 2024

BUY
$165.67 - $199.94 $15.4 Million - $18.5 Million
92,655 Added 9.83%
1,035,068 $175 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $180,819 - $238,907
1,194 Added 0.13%
942,413 $186 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $55.1 Million - $63.5 Million
329,543 Added 53.88%
941,219 $164 Million
Q2 2023

Aug 15, 2023

BUY
$160.94 - $186.23 $3.71 Million - $4.3 Million
23,075 Added 3.92%
611,676 $105 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $13.9 Million - $16.8 Million
95,830 Added 19.45%
588,601 $98 Million
Q4 2022

Jan 27, 2023

BUY
$131.14 - $157.47 $8.98 Million - $10.8 Million
68,454 Added 16.13%
492,771 $72.2 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $849,108 - $1.05 Million
-5,726 Reduced 1.33%
424,317 $62.9 Million
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $8.22 Million - $10.5 Million
52,674 Added 13.96%
430,043 $73.9 Million
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $2.04 Million - $2.63 Million
-11,256 Reduced 2.9%
377,369 $71.2 Million
Q4 2021

Feb 08, 2022

BUY
$193.69 - $247.03 $3.67 Million - $4.68 Million
18,955 Added 5.13%
388,625 $94.8 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $2.87 Million - $3.18 Million
-15,167 Reduced 3.94%
369,670 $71.8 Million
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $4.26 Million - $5.14 Million
27,350 Added 7.65%
384,837 $71.7 Million
Q1 2021

May 05, 2021

SELL
$144.0 - $169.39 $460,224 - $541,370
-3,196 Reduced 0.89%
357,487 $56.3 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $12.9 Million - $14.3 Million
82,047 Added 29.45%
360,683 $59.7 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $416,098 - $501,897
-3,035 Reduced 1.08%
278,636 $46.1 Million
Q2 2020

Aug 11, 2020

BUY
$111.92 - $142.53 $5.76 Million - $7.33 Million
51,462 Added 22.35%
281,671 $38.6 Million
Q1 2020

Apr 27, 2020

BUY
$92.66 - $144.94 $2.24 Million - $3.51 Million
24,225 Added 11.76%
230,209 $27.1 Million
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $403,271 - $462,244
3,469 Added 1.71%
205,984 $27.3 Million
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $112,119 - $127,916
996 Added 0.49%
202,515 $25.2 Million
Q2 2019

Aug 12, 2019

SELL
$97.98 - $114.28 $260,626 - $303,984
-2,660 Reduced 1.3%
201,519 $22.9 Million
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $795,699 - $982,136
9,756 Added 5.02%
204,179 $20.6 Million
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $137,233 - $164,912
-1,731 Reduced 0.88%
194,423 $16.6 Million
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $1.26 Million - $1.41 Million
15,136 Added 8.36%
196,154 $18 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $2.26 Million - $2.52 Million
28,223 Added 18.47%
181,018 $0
Q1 2018

May 10, 2018

BUY
$71.51 - $84.69 $1.31 Million - $1.55 Million
18,353 Added 13.65%
152,795 $12.8 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $1.27 Million - $1.47 Million
-20,134 Reduced 13.03%
134,442 $9.69 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $9.23 Million - $10.1 Million
154,576
154,576 $9.86 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.